Drugs / mucoid exopolysaccharide P. aeruginosa immune globulin
mucoid exopolysaccharide P. aeruginosa immune globulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00004747 | Jul 1995 → ? | bacterial infectious disease, cystic fibrosis | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mucoid exopolysaccharide P. aeruginosa immune globulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004747 ↗ |
| Route | Intravenous | “monthly intravenous mucoid exopolysaccharide Pseudomonas aeruginosa immune globulin (MEP IGIV)” NCT00004747 ↗ |